Published on September 14, 2009 at 4:57 AM
Research and Markets (http://www.researchandmarkets.com/research/3e6a10/drug_therapeutics) has announced the addition of the "Drug Therapeutics: Therapeutic Proteins" report to their offering.
In recent years, the number of protein-based pharmaceuticals reaching the marketplace has increased exponentially. The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution. It therefore becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively for parenteral administration. These combination drug-device products, where the drug and device are clinically tested and approved as a single product entity, are becoming one of the fastest new drug categories. On a unit basis, in spite of their higher cost protein drugs are growing in excess of fifteen percent annually. The growth of protein drug products is having a significant effect on the way drugs and devices are developed. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies.
Feature Summary:
- Analyzes approved therapeutic protein products and pipeline candidates and assesses the impact of formulation and delivery strategies on the market potential for existing and probable future protein drugs
- Examines protein delivery design issues, packaging, distribution and technology factors
- Assesses the role of protein formulation decisions on therapeutic protein commercialization and market potential
- Examines historical protein drug data for nine major therapeutic segments and provides forecasts by disease segment to 2012
- Profiles therapeutic protein companies, their commercial products, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on the successful commercialization of therapeutic proteins
http://www.researchandmarkets.com